Floratine Products Group Inc
Biotechnology ResearchTennessee, United States11-50 Employees
Floratine Products Group Inc is a Biotechnology company located in 355 E South St, Collierville, TN, United States.
Niche Biotechnology Focus Floratine Products Group operates within the biotechnology research sector, presenting opportunities to offer specialized software, research tools, or laboratory supplies tailored to biotech R&D needs.
Moderate Revenue Scale With an annual revenue between 10 and 25 million dollars, the company may be in a growth or scaling phase, making it receptive to investments in innovative solutions that can enhance efficiency or product development.
Small but Focused Team The company’s relatively small workforce suggests agility and openness to adopting new technologies or partnerships that can streamline operations or expand research capabilities.
Regional Presence Located in Collierville, Tennessee, Floratine has a regional footprint that favors localized marketing efforts, government grants, or regional industry collaborations to support its growth objectives.
Competitive Landscape Operating alongside industry giants like Syngenta and Corteva, Floratine can leverage niche or specialized products to differentiate itself, creating opportunities for tailored solutions that address unique biotech research challenges.
Floratine Products Group Inc uses 8 technology products and services including Open Graph, WordPress, JSON-LD, and more. Explore Floratine Products Group Inc's tech stack below.
| Floratine Products Group Inc Email Formats | Percentage |
| FLast@floratine.com | 69% |
| First.Last@floratine.com | 23% |
| LastF@floratine.com | 4% |
| Last@floratine.com | 4% |
Biotechnology ResearchTennessee, United States11-50 Employees
Floratine Products Group Inc is a Biotechnology company located in 355 E South St, Collierville, TN, United States.
Floratine Products Group Inc's revenue is estimated to be in the range of $10M$25M
Floratine Products Group Inc's revenue is estimated to be in the range of $10M$25M